Gender differences in arrhythmias
- 1 February 2002
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 25 (2) , 49-56
- https://doi.org/10.1002/clc.4950250203
Abstract
Electrocardiographic and electrophysiologic differences between men and women have long been noted. Women have a higher intrinsic heart rate than men, along with a longer corrected QT interval and a shorter sinus nodal recovery time. The incidence of and risk factors for a variety of arrhythmias differ between men and women. Atrioventricular nodal reentry tachycardia has a 2:1 female‐to‐male predominance, while accessory pathways are twice as frequent in men. Although atrial fibrillation is more prevalent in men of all age groups, the absolute numbers of men and women with atrial fibrillation are equal, and the associated morbidity and mortality experienced by women with atrial fibrillation appear to be worse. Women have a lower incidence of sudden cardiac death, and female survivors of sudden cardiac death have a lower frequency of spontaneous or inducible ventricular tachycardia. On the other hand, drug‐induced torsade de pointes and symptomatic long QT syndrome have a female predominance. Therefore, greater caution should be used when prescribing QT‐prolonging drugs in women. The incidence of arrhythmias is increased during pregnancy, and management of pregnant patients poses a significant challenge. The mechanisms of these gender differences are unclear but may be related to hormonal effects and the shorter QT interval in adult males. Pharmacologic and nonpharmacologic therapies are usually equally efficacious, but the risks of pharmacologic therapy are different in men and women. Atrial fibrillation may be more difficult to treat in women.Keywords
This publication has 53 references indexed in Scilit:
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Sex Steroids and Cardiac Arrhythmia:Journal of Cardiovascular Electrophysiology, 1998
- Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.The American Journal of Cardiology, 1998
- Malignant Sustained Ventricular Tachyarrhythmias in Women:.Journal of Cardiovascular Electrophysiology, 1997
- Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular functionThe American Journal of Cardiology, 1993
- Age at onset and gender of patients with different types of supraventricular tachycardiasThe American Journal of Cardiology, 1992
- New-onset ventricular tachycardia during pregnancyAmerican Heart Journal, 1992
- WPW syndrome during pregnancy: Increased incidence of supraventricular arrhythmiasAmerican Heart Journal, 1992
- Risk for systemic embolization of atrial fibrillation without mitral stenosisThe American Journal of Cardiology, 1990
- The normal duration of the Q-T intervalAmerican Heart Journal, 1942